XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

1 - 2 of 2 search results for !padrenullquery -UclCommunicationType:"announcement" UclOrgUnit:"cancer institute"

Results

  1. New ovarian cancer drug based on UCL research | UCL Cancer Institute…

    https://www.ucl.ac.uk/cancer/news/2018/jan/new-ovarian-cancer-drug-based-ucl-research

    2 Jan 2018: A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK. Professor Jonathan Ledermann, who led the research, said the drug was a “critical milestone” in managing the disease if

    A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK. Professor Jonathan Ledermann, who led the research, said the drug was a “critical milestone” in managing the disease if

  2. Immunotherapy discovery a step towards treating T cell cancers | UCL…

    https://www.ucl.ac.uk/cancer/news/2018/jan/immunotherapy-discovery-step-towards-treating-t-cell-cancers

    2 Jan 2018: Researchers have discovered a new way of potentially treating mature T cell cancers using immunotherapy. The study, published in Nature Medicine, demonstrates how chimeric antigen receptor (CAR) T cells can be used to selectively target cancerous T

    Researchers have discovered a new way of potentially treating mature T cell cancers using immunotherapy. The study, published in Nature Medicine, demonstrates how chimeric antigen receptor (CAR) T cells can be used to selectively target cancerous T

Pagination

Refine

Subjects : all → rt-cancer

Organisational Units

Communication types